Can Inflammatory Indices Predict Myringosclerosis

dc.contributor.author Sari, Neslihan
dc.contributor.author Savas, Hasan Basri
dc.contributor.author Ugras, Seda
dc.contributor.author Durucu, Cengiz
dc.date.accessioned 2025-12-15T15:46:30Z
dc.date.available 2025-12-15T15:46:30Z
dc.date.issued 2025
dc.description.abstract Objectives: To examine the relationships between the neutrophil-to-lymphocyte ratio (NLR), the platelet-to-lymphocyte ratio (PLR), and the systemic immune-inflammation index (SII) in myringosclerosis after ventilation tube insertion (VTI). Methods: We conducted this descriptive case-control study between March 2022 and September 2024. A total of 75 children aged 6 to 12 years with a history of VTI were enrolled. Myringosclerosis+ (n=43) included children with myringosclerosis, while Myringosclerosis-(n=32) included children without myringosclerosis. Preoperative values for NLR, PLR, and SII were collected by hematological testing and calculations. Demographic factors, prognostic risk factors and discrimination power of parameters were determined by statistical methods. Results: Compared to the myringosclerosis-, the myringosclerosis+ had significantly higher NLR, PLR, and SII values (p=0.00, p=0.04, and p=0.01, respectively). Receiver operating characteristic (ROC) curve area of NLR is 0,76 (95% CI: 0.65-0.87, p=0.00). Area under curve of SII is 0,62 (95%CI: 0.57-0.81, p=0.01). Neutrophil-to-lymphocyte ratio affects myringosclerosis development at 1.34 with sensitivity=0.63, specificity=0.78. Neutrophilto-lymphocyte ratio(NLR) and systemic immune inflammation index(SII) show myringosclerosis development at different powers of predictivity. The ROC area of NLR is highest of all parameters but is moderately predictive (<0.80). It is slight for SII. The NLR may be a marker of prediction of myringosclerosis OR=0.182 (95%CI:0.067-0.496). Conclusion: Neutrophil-to-lymphocyte ratio and SII are systemic inflammatory prognostic markers in myringosclerosis, and elevated NLR values are a predictor of myringosclerosis with modest affect. Other parameters should be sought in myringosclerosis development. en_US
dc.identifier.doi 10.15537/smj.2025.46.11.20250084
dc.identifier.issn 0379-5284
dc.identifier.issn 1658-3175
dc.identifier.uri https://doi.org/10.15537/smj.2025.46.11.20250084
dc.identifier.uri https://hdl.handle.net/20.500.12514/10034
dc.language.iso en en_US
dc.publisher Saudi Med J en_US
dc.relation.ispartof Saudi Medical Journal en_US
dc.rights info:eu-repo/semantics/openAccess en_US
dc.subject Neutrophil en_US
dc.subject Lymphocyte en_US
dc.subject Serous Otitis Media en_US
dc.subject Myringosclerosis en_US
dc.title Can Inflammatory Indices Predict Myringosclerosis en_US
dc.type Article en_US
dspace.entity.type Publication
gdc.author.wosid Sari, Neslihan/Gpp-3974-2022
gdc.author.wosid Ugras, Seda/Jsl-7097-2023
gdc.author.wosid Savas, Hasan Basri/Jts-6948-2023
gdc.coar.access open access
gdc.coar.type text::journal::journal article
gdc.description.department Artuklu University en_US
gdc.description.departmenttemp [Sari, Neslihan; Durucu, Cengiz] Mardin Artuklu Univ, Med Fac, Dept Otolaryngol, Mardin, Turkiye; [Savas, Hasan Basri] Mardin Artuklu Univ, Med Fac, Dept Biochem, Mardin, Turkiye; [Ugras, Seda] Mardin Artuklu Univ, Med Fac, Dept Physiol, Mardin, Turkiye; [Sari, Neslihan; Durucu, Cengiz] Clin Otorhinolaryngol, Mardin, Turkiye en_US
gdc.description.issue 11 en_US
gdc.description.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
gdc.description.scopusquality Q2
gdc.description.volume 46 en_US
gdc.description.woscitationindex Science Citation Index Expanded
gdc.description.wosquality Q2
gdc.identifier.openalex W7105695102
gdc.identifier.pmid 41224346
gdc.identifier.wos WOS:001622819900007
gdc.openalex.fwci 0.0
gdc.openalex.normalizedpercentile 0.8
gdc.opencitations.count 0
gdc.virtual.author Durucu, Cengiz
gdc.virtual.author Savaş, Hasan Basri
gdc.wos.citedcount 0
relation.isAuthorOfPublication 946a7d85-5bca-4cc5-9385-6d4c60cb858d
relation.isAuthorOfPublication 5d417990-416c-4199-b2fa-de0d6f23407b
relation.isAuthorOfPublication.latestForDiscovery 946a7d85-5bca-4cc5-9385-6d4c60cb858d
relation.isOrgUnitOfPublication ba421768-5f1e-47b4-9440-6a077f5f161d
relation.isOrgUnitOfPublication 699b05f8-13b6-432a-a67f-7cf80b49367a
relation.isOrgUnitOfPublication 3f27f943-1869-4252-af6a-9ec8b114c727
relation.isOrgUnitOfPublication 39ccb12e-5b2b-4b51-b989-14849cf90cae
relation.isOrgUnitOfPublication.latestForDiscovery ba421768-5f1e-47b4-9440-6a077f5f161d

Files